On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 ...

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines.

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing ...

The virus killed at least 20 million people, wiped at least $10 trillion from the global economy and upended billions of ...

As part of The Post’s exclusive Mount Postmore series, our experts name the four greatest New York hockey figures of all time.

Cornerstone Wealth Group LLC doubled down on Regeneron Pharmaceuticals, increasing its holdings by 114% in Q1. The fund now owns 8,270 shares worth over $5.2 million, signaling high confidence in ...

As both the chief people officer and chief operating officer of Brinker’s brands, the parent company behind restaurant chains Chili’s and Maggiano’s, nearly half of her time is spent on-site ...

Plus more pharma news from the Pharmalot campus, brought to you by the Pharmalittle newsletter.

FREMONT, Calif., June 26, 2025 /PRNewswire/ -- Ultima Genomics, a developer of an innovative new ultra-high throughput sequencing architecture, today announced that its UG 100 ™ sequencing platform ...